Women with a primary breast cancer (PBC) diagnosis and a pathogenic germline mutation in the BRCA1 or BRCA2 gene are at increased risk of developing metachronous contralateral breast cancer (CBC). This evidence concerns the gene BRCA1 and breast carcinoma.